Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22712,230,1.31 [1.15-1.49],3.3066941666775174e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",22680,229,1.47 [1.33-1.61],1.0079670992837836e-14
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,22987,233,1.79 [1.34-2.38],7.168981714687204e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,19432,206,0.48 [0.32-0.71],0.0003238382002655
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,22220,226,1.46 [1.19-1.79],0.0003130709272171
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,22747,232,1.32 [1.12-1.55],0.0009210106214636
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,22633,228,1.72 [1.39-2.12],3.73521808807891e-07
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,21967,226,1.59 [1.38-1.83],1.4624609527093547e-10
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,19841,209,2.55 [2.08-3.14],7.74371630549787e-19
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,23058,234,0.46 [0.30-0.69],0.0002199277550277
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,23035,233,2.29 [1.90-2.78],1.3928789727723806e-17
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,19339,200,1.18 [1.07-1.30],0.0007497261713185
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,22747,232,1.93 [1.50-2.49],4.1818029274449067e-07
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,19432,206,0.83 [0.74-0.93],0.0007925391538991
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,19846,210,1.95 [1.36-2.81],0.0003120877006208
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,18960,201,1.46 [1.18-1.80],0.0003920632597846
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,23058,234,1.68 [1.37-2.07],7.661069145117031e-07
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,22785,231,0.54 [0.39-0.75],0.0002616737642053
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,23035,233,1.77 [1.29-2.44],0.0004177850579508
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,22785,231,1.83 [1.41-2.38],6.3399461037433495e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19258,202,1.84 [1.37-2.46],4.472719089393572e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,22358,230,1.37 [1.14-1.64],0.0006782920942246
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,22995,233,1.68 [1.37-2.05],5.576973897027889e-07
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,22805,231,1.48 [1.21-1.81],0.0001442172680769
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,22751,230,1.46 [1.20-1.77],0.0001481118191775
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,22647,227,1.40 [1.18-1.66],9.325221780200792e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,19744,207,0.76 [0.66-0.89],0.0005263342803743
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,22984,231,0.39 [0.23-0.65],0.0003614631956127
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,22643,231,1.32 [1.13-1.55],0.0006468902265907
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,22503,228,2.82 [2.11-3.79],4.113807655845966e-12
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,19432,206,0.84 [0.76-0.93],0.0008979899627876
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,22747,232,1.44 [1.22-1.71],2.427966333726237e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,22701,228,1.88 [1.46-2.42],1.1918442713348822e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,19846,210,2.28 [1.52-3.42],6.821561362277904e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,22813,229,0.67 [0.55-0.81],3.313008850445829e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,19240,201,1.64 [1.26-2.14],0.0002230803331529
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,19795,210,3.55 [1.76-7.19],0.0004240083710194
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,19831,210,2.23 [1.39-3.57],0.0008637921436639
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,22272,229,1.46 [1.22-1.75],3.741631319371609e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,22785,231,1.37 [1.15-1.62],0.0003326131669693
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,22987,233,0.52 [0.39-0.71],2.8353140951612582e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,19738,207,0.58 [0.44-0.77],0.0001807789479269
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,22729,231,2.16 [1.44-3.24],0.0002106141453733
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19465,206,0.78 [0.69-0.89],0.0001636113955799
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22633,228,1.36 [1.15-1.61],0.0002964785458633
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22633,228,1.44 [1.20-1.72],7.009171257982199e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,23018,233,1.79 [1.28-2.51],0.0006748296684998
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,22633,228,0.56 [0.44-0.73],1.137443707548913e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,22777,229,1.62 [1.32-2.00],4.3836150435281525e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,21609,219,2.37 [1.87-3.01],1.2024844937068504e-12
